2026-09-20T02:02:46Zhttps://dspace.mit.edu/server/oai/requestoai:dspace.mit.edu:1721.1/596792026-06-06T01:06:05Zcom_1721.1_7582com_1721.1_7581col_1721.1_131023
Kenneth A. Oye.
Gonzalez, Muriel Eugenia
Massachusetts Institute of Technology. Technology and Policy Program.
Massachusetts Institute of Technology. Engineering Systems Division
2010-10-29T18:10:16Z
2010-10-29T18:10:16Z
2010
2010
http://hdl.handle.net/1721.1/59679
668222494
Thesis (S.M. in Technology and Policy)--Massachusetts Institute of Technology, Engineering Systems Division, Technology and Policy Program, 2010.
Cataloged from PDF version of thesis.
Includes bibliographical references (p. 75-80).
The effects of Intellectual Property Rights (IPRs) on innovation in the field of biotechnology are considered through assessment of their effects on upstream innovation and downstream development. Two case studies involving research tools representing forms of upstream innovation are analyzed to identify factors enabling or hindering downstream innovation. The proprietary technologies of recombinant DNA (rDNA) and Polymerase Chain Reaction (PCR) are assessed in relation to both their development and their diffusion strategies. Factors considered are: the type of IPRs, legal circumstances, the strategy regarding disclosure, whether a basic research exemption exists, enforcement of IPRs, the invention's characteristics, the economic resources available (private vs. public), and the development setting. Assessment of these cases requires consideration of the current intellectual property regime and its associated problems. These principally include the importance of the context (including the legal framework), the strategy adopted by the owners of the IPRs regarding diffusion, the type of development setting, and the invention's characteristics. Ways of dealing with these issues within the traditional IPR systems are assessed, such as patents and trade secrets, for which corresponding types of licenses can provide solutions. Additionally, new approaches are assessed, such as patent pools, clearinghouses, open source models, liability regimes, experimental use exemption, and compulsory licensing. These alternatives are considered both in the United States and under different international regimes. Finally, the potential policy implications of IPRs, both in the United States and internationally, are evaluated with regard to their effects on innovation in biotechnology.
by Muriel Eugenia Gonzalez.
S.M. in Technology and Policy
84 p.
eng
Massachusetts Institute of Technology
M.I.T. theses are protected by
copyright. They may be viewed from this source for any purpose, but
reproduction or distribution in any format is prohibited without written
permission. See provided URL for inquiries about permission.
http://dspace.mit.edu/handle/1721.1/7582
Engineering Systems Division.
Technology and Policy Program.
The effects of intellectual property on innovation : implications for R&D in biotechnology
Thesis
application/pdf
false
Publication
unknown
unknown
<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="06879705-cddc-4b28-b0cc-4b6c6a72cdd1">
<Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type>
<Language>eng</Language>
<Title>The effects of intellectual property on innovation : implications for R&D in biotechnology</Title>
<PublishedIn>
<Publication>
</Publication>
</PublishedIn>
<PublicationDate>2010</PublicationDate>
<Authors>
<Author>
<DisplayName>Gonzalez, Muriel Eugenia</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
</Authors>
<Editors>
</Editors>
<Publishers>
<Publisher>
<DisplayName>Massachusetts Institute of Technology</DisplayName>
<OrgUnit />
</Publisher>
</Publishers>
<License>http://dspace.mit.edu/handle/1721.1/7582</License>
<Keyword>Engineering Systems Division.</Keyword>
<Keyword>Technology and Policy Program.</Keyword>
<Abstract>The effects of Intellectual Property Rights (IPRs) on innovation in the field of biotechnology are considered through assessment of their effects on upstream innovation and downstream development. Two case studies involving research tools representing forms of upstream innovation are analyzed to identify factors enabling or hindering downstream innovation. The proprietary technologies of recombinant DNA (rDNA) and Polymerase Chain Reaction (PCR) are assessed in relation to both their development and their diffusion strategies. Factors considered are: the type of IPRs, legal circumstances, the strategy regarding disclosure, whether a basic research exemption exists, enforcement of IPRs, the invention's characteristics, the economic resources available (private vs. public), and the development setting. Assessment of these cases requires consideration of the current intellectual property regime and its associated problems. These principally include the importance of the context (including the legal framework), the strategy adopted by the owners of the IPRs regarding diffusion, the type of development setting, and the invention's characteristics. Ways of dealing with these issues within the traditional IPR systems are assessed, such as patents and trade secrets, for which corresponding types of licenses can provide solutions. Additionally, new approaches are assessed, such as patent pools, clearinghouses, open source models, liability regimes, experimental use exemption, and compulsory licensing. These alternatives are considered both in the United States and under different international regimes. Finally, the potential policy implications of IPRs, both in the United States and internationally, are evaluated with regard to their effects on innovation in biotechnology.</Abstract>
<Access xmlns="http://purl.org/coar/access_right"
>
</Access>
</Publication>